Document is current
Any future updates will be listed below
-
Authors
Fukahori, Masaru https://orcid.org/0000-0002-4916-6381
Shibata, Masayuki
Hamauchi, Satoshi
Kasamatsu, Eiji
Machii, Koji
-
Funding
Funding for this research was provided by:
Ono Pharmaceutical (none)
- License Information
-
More Information
Article History
Received: 26 November 2019
Accepted: 17 April 2020
First Online: 3 May 2020
Compliance with ethical standards
: This study was approved by the ethics review committees of Kurume University Hospital (reference 18,076) and Shizuoka Cancer Center (reference T30-31-30-1-7).
: Masayuki Shibata and Satoshi Hamauchi have received research funds from Ono Pharmaceutical Co., Ltd. Masaru Fukahori has received research funds from Ono Pharmaceutical Co., Ltd. and personal fees from Merck. Eiji Kasamatsu and Koji Machii are employees of Ono Pharmaceutical Co., Ltd.
: Qualified researchers may request Ono Pharma to disclose individual patient-level data from clinical studies through the following website: . For more information on Ono Pharma’s Policy for the Disclosure of Clinical Study Data, please see the following website: .
